Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in septic acute kidney injury
NCT03877081Phase 3Unknown
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Jan 2019
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute kidney injury (AKI) (2 arms), sponsored by Hospital Civil de Guadalajara. Primary endpoint: Serum creatinine at 7 days. Status: unknown.
02
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03877081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03877081.